Detalhe da pesquisa
1.
Safety and reactogenicity of DTPa-HBV-IPV/Hib and DTPa-IPV/I-Hib vaccines in a post-marketing surveillance setting.
Southeast Asian J Trop Med Public Health
; 42(1): 138-47, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21323176